Company Coretech 5

Equities

MLCOT

FR0013371507

Real-time Euronext Paris Other stock markets 05:30:27 2024-06-27 EDT			5-day change	1st Jan Change
0.025 ^EUR	-.--%		-16.67%	+400.00%

2023	Gour Medical SA announced that it has received â‚¬0.135 million in funding	CI
2023	Gour Medical SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Business Summary

Coretech 5 specializes in the development and commercialization of innovative veterinary solutions for the management of the main pathologies of companion animals. Its unique positioning is based in particular on the use of natural products based on hemp extracts. Devoid of psychoactive effects, WEEDLEY, its first range of premium solutions, increases the effectiveness of cannabidiol thanks to the surround effect.

Managers

Managers	Title	Age	Since
Serge Goldner CEO	Chief Executive Officer	59	14-07-13
Eva Bleul LAW	General Counsel	-	-
Marie Bénédicte Charpentier SAM	Sales & Marketing	-	-

Members of the board

Members of the board	Title	Age	Since
Gilles Avenard BRD	Director/Board Member	-	19-02-28
Christian Grandjean BRD	Director/Board Member	65	-
Serge Goldner CEO	Chief Executive Officer	59	14-07-13

Company contact information

Coretech 5 SA

5 rue de Castiglione

75001, Paris

+33 1 42 46 11 73

http://www.gour-medical.com

Sector

This company's sector is not yet available